PubAg

Main content area

Anti-Prion Systems in Yeast and Inositol Polyphosphates

Author:
Wickner, Reed B., Bezsonov, Evgeny E., Son, Moonil, Ducatez, Mathieu, DeWilde, Morgan, Edskes, Herman K.
Source:
Biochemistry 2018 v.57 no.8 pp. 1285-1292
ISSN:
1520-4995
Subject:
amyloid, inositols, mammals, models, polymers, polyphosphates, prion diseases, prions, signal transduction, therapeutics, yeasts
Abstract:
The amyloid-based yeast prions are folded in-register parallel β-sheet polymers. Each prion can exist in a wide array of variants, with different biological properties resulting from different self-propagating amyloid conformations. Yeast has several anti-prion systems, acting in normal cells (without protein overexpression or deficiency). Some anti-prion proteins partially block prion formation (Ssb1,2p, ribosome-associated Hsp70s); others cure a large portion of prion variants that arise [Btn2p, Cur1p, Hsp104 (a disaggregase), Siw14p, and Upf1,2,3p, nonsense-mediated decay proteins], and others prevent prion-induced pathology (Sis1p, essential cytoplasmic Hsp40). Study of the anti-prion activity of Siw14p, a pyrophosphatase specific for 5-diphosphoinositol pentakisphosphate (5PP-IP5), led to the discovery that inositol polyphosphates, signal transduction molecules, are involved in [PSI+] prion propagation. Either inositol hexakisphosphate or 5PP-IP4 (or 5PP-IP5) can supply a function that is needed by nearly all [PSI+] variants. Because yeast prions are informative models for mammalian prion diseases and other amyloidoses, detailed examination of the anti-prion systems, some of which have close mammalian homologues, will be important for the development of therapeutic measures.
Agid:
5986967